Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:icatibant
|
| gptkbp:approvalYear |
2011
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:European_Medicines_Agency |
| gptkbp:ATCCode |
B06AC02
|
| gptkbp:countryOfOperation |
gptkb:European_Union
gptkb:United_States |
| gptkbp:form |
solution for injection
pre-filled syringe |
| https://www.w3.org/2000/01/rdf-schema#label |
Firazyr
|
| gptkbp:indication |
acute attacks of hereditary angioedema
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Shire
|
| gptkbp:mechanismOfAction |
bradykinin B2 receptor antagonist
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
fever
nausea dizziness injection site reaction |
| gptkbp:usedFor |
gptkb:hereditary_hemorrhagic_telangiectasia
|
| gptkbp:bfsParent |
gptkb:Takeda
gptkb:Takeda_(Japan) |
| gptkbp:bfsLayer |
6
|